Logo
News NBE Therapeutics in the News Events

News

2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
Select a year
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012

December 31 - Unites States Patent and Trademark Office grants second US patent on NBE's linker-toxin technology

Read more

November 7 - SOTIO exercises second target option under existing collaboration with NBE-Therapeutics to develop next-generation antibody-drug conjugates

Read more

October 8 - Dr. Steffen Heeger appointed as new Chief Medical Officer of NBE-Therapeutics

Read more

April 9 - WuXi Biologics and NBE Therapeutics Announce Comprehensive ADC Development and Manufacturing Partnership

Read more

March 13 - NBE to Present Late-Breaking Abstract on Lead ADC Program NBE-002 (ROR1) at the AACR Annual Meeting

Read more

January 29 - Unites States Patent and Trademark Office grants US patent on NBE's linker-toxin technology

Read more